- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00639912
Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction. (CINIMA)
Randomized Trial on the Effects of Hydration With Sodium Chloride Versus Sodium Bicarbonate to Prevent Contrast Induced Nephropathy, in Patients Undergoing Primary Coronary Interventions for Acute ST Elevation Myocardial Infarction.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Contrast-induced nephropathy (CIN) is associated with increased morbidity and mortality after percutaneous coronary interventions (PCI). Patients with ST elevation myocardial infarction (STEMI) are at high risk for CIN because of hemodynamic instability of the patient, inability to prevent the phenomenon (hydration) and the possible exposure to high volume of contrast media. Recent reports have shown incidence of CIN up to 19% in this population and a related increase of in-hospital mortality.
Merten e coll. (JAMA 2004) reported that sodium bicarbonate infusion before and after contrast exposure in patients with chronic renal failure and without myocardial infarction (AMI) is more effective than sodium chloride in preventing CIN.
Up to date there is no evidence of any effective prophylactic measures in patients with STEMI undergoing primary PCI.
The aim of the study is to test the efficacy of low versus high volume hydration and the efficacy of two different solutions (sodium chloride versus sodium bicarbonate) in preventing CIN in STEMI patients undergoing primary PCI.
The infusion of the randomized solution will start just after randomization and after determination of baseline serum creatinine.
Determination of serum creatinine will be repeated at 24, 48 and 72 hours after randomization. Creatinine clearance will be calculated with Cockroft-Gault formula and MDRD.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Parma, Italy, 43100
- Dipartimento di Cardiologia, Ospedale Maggiore
-
-
Emilia-Romagna
-
Modena, Emilia-Romagna, Italy, 41100
- Nuovo Ospedale Civile di Baggiovara
-
Reggio Emilia, Emilia-Romagna, Italy, 42100
- Arcispedale S. Maria Nuova
-
-
Emilia-romagna
-
Ferrara, Emilia-romagna, Italy
- Azienda Ospedaliera Universitaria S. Anna
-
-
Genova
-
Lavagna, Genova, Italy, 16033
- Dipartimento di Cardiologia, Ospedale di Lavagna
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age > 18 years of years
- Chest pain lasting at least 30 minutes, non responsive to nitrates, associated to ST elevation of at least 0.2 mV on surface ECG in two or more contiguous leads or to new left bundle branch block.
- Informed consent
Exclusion Criteria:
- Chronic hemodialytic or peritoneal treatment
- Coronary anatomy unsuitable for PCI
- Need of emergency coronary artery by-pass grafting
- Post-anoxic coma
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: A: low volume saline
Solution of 154 mEq/L of sodium chloride.
Rate of infusion: 1 ml/kg/hour for 12 hours after the procedure, starting in the Cath Lab.
|
Solution of 154 mEq/L of sodium chloride.
Rate of infusion: 1 ml/Kg/hour for 12 hours.
Other Names:
Solution of 154 mEq/L of sodium chloride.
Rate of infusion: 3 ml/Kg for 1 hour, followed by 1 ml/Kg/hour for 12 hours
Other Names:
|
Active Comparator: B: high volume saline
Solution of 154 mEq/L of sodium chloride.
Rate of infusion: 3 ml/Kg for 1 hour, followed by 1 ml/Kg/hour for 12 hours after the procedure, starting in the Cath lab.
|
Solution of 154 mEq/L of sodium chloride.
Rate of infusion: 1 ml/Kg/hour for 12 hours.
Other Names:
Solution of 154 mEq/L of sodium chloride.
Rate of infusion: 3 ml/Kg for 1 hour, followed by 1 ml/Kg/hour for 12 hours
Other Names:
|
Active Comparator: C: low volume sodium bicarbonate
Solution of 154 mEq/L of sodium bicarbonate.
Rate of infusion: 1 ml/Kg/hour for 12 hours after the procedure, starting in the Cath Lab.
|
154 mEq/L of sodium bicarbonate in dextrose solution.
Rate of infusion: 1 ml/Kg/hour for 12 hours.
Other Names:
154 mEq/L of sodium chloride in dextrose solution.
Rate of infusion: 3 ml/Kg for 1 hour, followed by 1 ml/Kg/hour for 12 hours.
Other Names:
|
Active Comparator: D: high volume sodium bicarbonate
Solution of 154 mEq/L of sodium bicarbonate.
Rate of infusion: 3 ml/Kg for 1 hour, followed by 1 ml/Kg/hour for 12 hours after the procedure, starting in the Cath Lab.
|
154 mEq/L of sodium bicarbonate in dextrose solution.
Rate of infusion: 1 ml/Kg/hour for 12 hours.
Other Names:
154 mEq/L of sodium chloride in dextrose solution.
Rate of infusion: 3 ml/Kg for 1 hour, followed by 1 ml/Kg/hour for 12 hours.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
contrast induced nephropathy incidence
Time Frame: 24, 48 and 72 hours
|
24, 48 and 72 hours
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Antonio Manari, MD, Arcispedale S. Maria Nuova Reggio Emilia
Publications and helpful links
General Publications
- Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA 3rd, Rittase RA, Norton HJ, Kennedy TP. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004 May 19;291(19):2328-34. doi: 10.1001/jama.291.19.2328.
- Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, Grazi M, Veglia F, Bartorelli AL. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004 Nov 2;44(9):1780-5. doi: 10.1016/j.jacc.2004.07.043.
- McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, Tumlin J; CIN Consensus Working Panel. Risk prediction of contrast-induced nephropathy. Am J Cardiol. 2006 Sep 18;98(6A):27K-36K. doi: 10.1016/j.amjcard.2006.01.022. Epub 2006 Feb 23.
- Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, De Metrio M, Galli S, Fabbiocchi F, Montorsi P, Veglia F, Bartorelli AL. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med. 2006 Jun 29;354(26):2773-82. doi: 10.1056/NEJMoa054209.
- Manari A, Magnavacchi P, Puggioni E, Vignali L, Fiaccadori E, Menozzi M, Tondi S, Robotti S, Ferrari D, Valgimigli M. Acute kidney injury after primary angioplasty: effect of different hydration treatments. J Cardiovasc Med (Hagerstown). 2014 Jan;15(1):60-7. doi: 10.2459/JCM.0b013e3283641bb8.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MAN1374
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contrast Induced Nephropathy
-
Singapore General HospitalActive, not recruitingContrast-induced NephropathySingapore
-
Chinese PLA General HospitalUnknownContrast-induced NephropathyChina
-
Memorial University of NewfoundlandUniversity of AlbertaWithdrawnContrast Induced NephropathyCanada
-
Sun Yat-sen UniversityCompletedContrast Induced NephropathyChina
-
Isfahan University of Medical SciencesUnknownContrast-Induced NephropathyIran, Islamic Republic of
-
Mt. Sinai Medical Center, MiamiFlorida Heart Research InstituteCompleted
-
Kaiser PermanenteCompletedKidney Diseases | Contrast Induced NephropathyUnited States
-
Ospedale Misericordia e DolceCompletedContrast Induced NephropathyItaly
-
Guangdong Provincial People's HospitalGuangdong Medical College; Hainan People's HospitalUnknownContrast Induced NephropathyChina
-
University of ThessalyUnknownContrast Induced Nephropathy
Clinical Trials on sodium chloride
-
Imperial College LondonRoyal Brompton & Harefield NHS Foundation TrustCompletedNeuromuscular DiseasesUnited Kingdom
-
University of JenaCompletedCystic Fibrosis | RhinosinusitisGermany
-
Institut d'Anesthesiologie des Alpes MaritimesUniversité de Nice Sophia Antipolis; Medical University of GrenobleCompleted
-
Federal University of São PauloCompleted
-
Radboud University Medical CenterUnknownType1diabetes | Hypoglycemia UnawarenessNetherlands
-
Austin HealthCompletedSystemic Inflammatory Response Syndrome | Renal Impairment | OliguriaAustralia
-
Medical University of GrazCompleted
-
Osaka General Medical CenterCompletedEmergent Coronary ProcedureJapan
-
Lars Wiuff AndersenUniversity of AarhusRecruiting